Showing 61-70 of 1732 results for "".
- Advancements in Epilepsy Syndrome Diagnosis and Managementhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0208-epilepsy-dept-pdf/31051/Advancements in Epilepsy Syndrome Diagnosis and ManagementEpilepsy, one of the most historically recognized neurological disorders, remains the second most prevalent neurological condition, affecting approximately one percent of the global population. In the United States and Europe, new epilepsy ca
The Role of Abuse Deterrent Formulations of Opioids in Pain Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-role-of-abuse-deterrent-formulations-of-opioids-in-pain-management/30408/An emerging class of potentially safer opioid medications will offer new challenges and opportunities for both patients and physicians.Innovations in Neuroscience
https://practicalneurology.com/diseases-diagnoses/imaging-testing/innovations-in-neuroscience/30482/Epilepsy Caregiving
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-caregiving/30082/Caregivers play an important part in the patient journey, especially with conditions such as epilepsy. Actor and podcast host of "Talk About It!" Greg Grunberg discusses how caregivers can educate themselves and their loved ones about how best to thrive.- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn1207-dementiainsight-pdf/31076/Curcumin and Its Potential in Alzheimer's Disease ManagementAlzheimer’s disease (AD) remains a formidable challenge in neurology, prompting researchers to explore novel therapeutic avenues. One promising candidate is curcumin, a bioactive compound found in turmeric, a staple spice in South Asian cui
Disparities in Alzheimer Disease and Alzheimer-Related Dementias: Considerations for Clinical Decision-Making and Treatment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/disparities-in-alzheimer-disease-and-alzheimer-related-dementias-considerations-for-clinical-decision-making-and-treatment/32016/Taking into account social determinants of health and identifying solutions to improve patient care.Neuromodulation Strategies for Lennox-Gastaut Syndrome: A New Frontier
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/neuromodulation-strategies-for-lennox-gastaut-syndrome-a-new-frontier/39964/The evolution of neuromodulation strategies for the management of Lennox- Gastaut syndrome emphasizes the role of targeted thalamic stimulation, the importance of individualized approaches, and the need for further research to optimize treatment efficacy.Online Bonus: Opioid Dependence: Misperceptions Abound, but Physicians Can Help
https://practicalneurology.com/diseases-diagnoses/headache-pain/opioid-dependence-misperceptions-abound-but-physicians-can-help/30721/Brain Stimulation and Robotics-Assisted Motor Training: New Frontiers in Physical Therapy?
https://practicalneurology.com/diseases-diagnoses/stroke/brain-stimulation-and-robotics-assisted-motor-training-new-frontiers-in-physical-therapy/30660/A new approach may help patients recover from stroke and other neurologic injuries. In part one of a series, a researcher explains the technique.Calcitonin Gene-Related Peptide, Monoclonal Antibodies, and Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/calcitonin-gene-related-peptide-monoclonal-antibodies-and-migraine/30404/The recent development of monoclonal antibodies for the treatment of migraine may have a significant impact on the field and mark a new chapter in patient care.